Catalytic and inhibitor binding properties of zebrafish monoamine oxidase (zMAO): Comparisons with human MAO A and MAO B

Comparative Biochemistry and Physiology - B Biochemistry and Molecular Biology

Volumn 159, Issue 2, 2011, Pages 78-83

  Aldeco, Milagros ^a   Arslan, Betül Kacar ^a,b   Edmondson, Dale E ^a  

^a EMORY UNIVERSITY   (United States)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Inhibitor binding; Monoamine oxidase; Substrate specificity; Zebrafish

Indexed keywords

1,4 DIPHENYL 1,3 BUTADIENE; 1,4 DIPHENYL 2 BUTENE; 8 (3 CHLOROSTYRYL)CAFFEINE; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BENZYLAMINE DERIVATIVE; DEXAMPHETAMINE; DOPAMINE; FARNESOL; HARMAN; METHYLENE BLUE; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; PIRLINDOLE; SAFINAMIDE; SEROTONIN; TETRINDOLE; TYRAMINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; CATALYSIS; ENZYME SPECIFICITY; HUMAN; NONHUMAN; OXIDATION; PRIORITY JOURNAL; STEADY STATE; STRUCTURE ACTIVITY RELATION; ZEBRA FISH;

DANIO RERIO;

EID: 79953314929     PISSN: 10964959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpb.2011.02.002     Document Type: Article

References (41)

1. Andreeva N.I., Golovina S.M., Mashkovskii M.D. A new antidepressant tetrindole II. Experimental investigation of tetrindole tolerability. J. Med. Pharm. Chem. 1992, 26:11-12.
2. Anichtchik O., Sallinen V., Peitsaro N., Panula P. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio). J. Comp. Neurol. 2006, 498:593-610.
3. Arslan B.K., Edmondson D.E. Expression of zebrafish (Danio rerio) monoamine oxidase (MAO) in Pichia pastoris: purification and comparison with human MAO A and MAO B. Protein Expr. Purif. 2010, 70:290-297.
4. Bach A.W., Lan N.C., Johnson D.L., Abell C.W., Bembenek M.E., Kwan S.W., Seeburg P.H., Shih J.C. cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties. Proc. Natl Acad. Sci. 1988, 85:4934-4938. USA.
5. Binda C., Newton-Vinson P., Hubalek F., Edmondson D.E., Mattevi A. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat. Struct. Biol. 2002, 9:22-26.
6. Binda C., Li M., Hubalek F., Restelli B., Edmondson D.E., Mattevi A. Insights into the mode of inhibiton of human mitochondrial monoamine oxidase B from high-resolution crystal structure. Proc. Natl Acad. Sci. 2003, 100:9750-9755. USA.
7. Binda C., Wang J., Pisani L., Caccia C., Carotti A., Salvati P., Edmondson D.E., Mattevi A. Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J. Med. Chem. 2007, 50:5848-5852.
8. Bondi A. Van der Waals volumes and radii. J. Phys. Chem. 1964, 68:441-451.
9. Chen K., Wu H.F., Grimsby J., Shih J.C. Cloning of a novel monoamine oxidase cDNA from trout liver. Mol. Pharmacol. 1994, 46:1226-1233.
10. De Colibus L., Li M., Binda C., Lustig A., Edmondson D.E., Mattevi A. Three-dimensional structure of human monoamine oxidase A (MAO A): relation to the structures of rat MAO A and human MAO B. Proc. Natl Acad. Sci. 2005, 102:12684-12689. USA.
11. Edmondson D.E., Binda C., Mattevi A. Structural insights into the mechanism of amine oxidation by monoamine oxidases A and B. Arch. Biochem. Biophys. 2007, 464:269-276.
12. Edmondson D.E., Binda C., Wang J., Upadhyay A., Mattevi A. Molecular and mechanistic properties of the membrane-bound mitochondrial monoamine oxidases. Biochemistry 2009, 48:4230-4430.
13. Gallivan J.P., Dougherty D.A. Cation-Π Interactions in Structural Biology. Proc. Natl. Acad. Sci. 1999, 96:9459-9464. USA.
14. Green A.L., El Hait M.A. p-methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo. J. Pharm. Pharmacol. 1980, 32:262-266.
15. Hansch C., Leo A., Hoekman D. Exploring QSAR. Hydrophobic, Electronic, and Steric Constants 1995, American Chemical Society, Washington, DC.
16. Hubálek F., Binda C., Khalil A., Li M., Mattevi A., Castagnoli N., Edmondson D.E. Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors. J. Biol. Chem. 2005, 280:15761-15766.
17. Klinman J.P., Matthews R.G. Calculation of substrate dissociation-constants from steady-state isotope effects in enzyme-catalyzed reactions. J. Am. Chem. Soc. 1985, 107:1058-1060.
18. Kokel D., Bryan J., Laggner C., White R., Cheung C.-Y.J., Mateus R., Healey D., Kim S., Werdich A.A., Haggarty S.J., MacRae C.A., Shoichet B., Peterson R.T. Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat. Chem. Biol. 2010, 6:231-237.
19. Li, M. 2006. Ph.D. Dissertation, Emory University.
20. Li M., Hubálek F., Newton-Vinson P., Edmondson D.E. High-level expression of human liver monoamine oxidase A in Pichia pastoris: comparison with the enzyme expressed in Saccharomyces cerevisiae. Protein Expr. Purif. 2002, 24:152-162.
21. McEwen C.M., Sasaki G., Jones D.C. Human liver mitochondrial monoamine oxidase I. Kinetic studies of model interactions. J. Biol. Chem. 1968, 243:5217-5225.
22. McEwen C.M., Sasaki G., Jones D.C. Human liver mitochondrial monoamine oxidase II. Determinants of substrate and inhibitor specificities. Biochemistry 1969, 8:3952-3962.
23. Milczek, E.M. 2010 Ph.D. Dissertation, Emory University.
24. Miller J.R., Edmondson D.E. Structure-activity relationships in the oxidation of para-substituted benzylamine analogues by recombinant human liver monoamine oxidase A. Biochemistry 1999, 38:13670-13683.
25. Morrison J.F. Kinetics of reversible inhibition of enzyme catalyzed reactions by tight binding inhibitors. Biochim. Biophys. Acta 1968, 185:269-286.
26. Nandigama R.K., Edmondson D.E. Structure-activity relations in the oxidation of phenethylamine analogues by recombinant human liver monoamine oxidase A. Biochemistry 2000, 39:15258-15265.
27. Newton-Vinson P., Hubálek F., Edmondson D.E. High-level expression of human liver monoamine oxidase B in Pichia pastoris. Protein Expr. Purif. 2000, 20:334-345.
28. Pearce L.B., Roth J.A. Human brain monoamine oxidase type B: mechanism of deamination as probed by steady state methods. Biochemistry 1985, 24:1821-1826.
29. Ramsay R.R., Dunford C., Gillman P.K. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br. J. Pharmacol. 2007, 152:946-951.
30. Rihel J., Prober D.A., Arvanites A., Lam K., Zimmerman S., Jang S., Haggerty S.J., Kokel D., Rubin L.L., Peterson R.T., Schier A.F. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010, 327:348-351.
31. Sallinen V., Sundvik M., Reenila I., Peitsaro N., Khrustalyov D., Anichtchik O., Toleikyte G., Kaslin J., Panula P. Hyperserotonergic phenotype after monoamine oxidase inhibition in larval zebrafish. J. Neurochem. 2009, 109:403-415.
32. Sallinen V., Torkko V., Sundvik M., Reenila I., Khrustalyov D., Kaslin J., Panula P. MPTP and MPP plus target specific aminergic cell populations in larval zebrafish. J. Neurochem. 2009, 108:719-731.
33. Setini A., Pierucci F., Senatori O., Nicotra A. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio). Comp. Biochem. Physiol. B 2005, 140:153-161.
34. Son S.-Y., Ma Jichun, Youhei Kondou, Masato Yoshimura, Eiki Yamashita, Tomitake Tsukihara Structure of human monoamine oxidase a at 2.2-Å resolution: the control of opening the entry for substrates/inhibitors. Proc. Natl Acad. Sci. 2008, 105:5739-5744. USA.
35. Sowa B.N., Holt A., Todd K.G., Baker G.B. Monoamine oxidase inhibitors, their structural analogues, and neuroprotection. Indian J. Exp. Biol. 2004, 42:851-857.
36. Upadhyay A.K., Edmondson D.E. Characterization of detergent purified recombinant rat liver monoamine oxidase B expressed in Pichia pastoris. Protein Expr. Purif. 2008, 59:349-356.
37. Vintén A.P.B., Price N.T., Silverman R.B., Ramsay R.R. Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines. Bioorg. Med. Chem. 2005, 13:3487-3495.
38. Walker M.C., Edmondson D.E. Structure-activity relationships in the oxidation of benzylamine analogs by bovine liver mitochondrial monoamine oxidase B. Biochemistry 1994, 33:7088-7098.
39. Wang J., Edmondson D.E. High-level expression and purification of rat monoamine oxidase A (MAO A) in Pichia pastoris: comparisons to human MAO A. Protein Expr. Purif. 2009, 70:211-217.
40. Wang J., Harris J., Mousseau D.D., Edmondson D.E. Mutagenic probes of the role of serine 209 on the cavity shaping loop of human monoamine oxidase A. FEBS J. 2009, 276:4569-4581.
41. Youdim M.B.H., Edmondson D.E., Tipton K.F. The therapeutic potential of monoamine oxidase inhibitors. Nat. Rev. Neurosci. 2006, 7:295-309.